Phibro Animal Health /
Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets
Phibro Animal Health to acquire Zoetis product portfolio




What happened
Phibro Animal Health agreed to buy Zoetis’ medicated feed additive portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments.
The portfolio includes more than 37 product lines sold in approximately 80 countries, and the agreement also includes six manufacturing sites.
The source
Everything on this page comes from the source below.
Phibro Animal Health to acquire Zoetis product portfolio
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly